Novo Nordisk CEO on Pricing, U.S. Investments, M&A

Novo Nordisk CEO on Pricing, U.S. Investments, M&A

Assessment

Interactive Video

Business, Other

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript covers a discussion on the company's pricing outlook for 2017, insights from a meeting with President Trump regarding regulatory changes, potential impacts of H1B visa changes, and the company's strategic focus on growth areas like diabetes and obesity. It also addresses share price performance and investor expectations.

Read more

3 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What opportunities does the speaker see in the obesity market?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What are the unmet medical needs in the diabetes space according to the speaker?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the speaker's outlook on the share price performance and investor expectations?

Evaluate responses using AI:

OFF